Fortitude Family Office’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.68M Hold
1,400
0.33% 52
2026
Q1
$1.29M Hold
1,400
0.29% 57
2025
Q4
$1.5M Hold
1,400
0.35% 58
2025
Q3
$1.07M Hold
1,400
0.29% 65
2025
Q2
$1.09M Hold
1,400
0.36% 54
2025
Q1
$1.16M Buy
1,400
+1,000
+250% +$832K 0.41% 38
2024
Q4
$309K Hold
400
0.11% 104
2024
Q3
$354K Hold
400
0.14% 87
2024
Q2
$362 Buy
+400
New +$320K ﹤0.01% 924

Other funds holding LLY

Fortitude Family Office's LLY Position: Q2 2026 in Review

Fortitude Family Office increased its Eli Lilly (LLY) stake by 1.7% in Q2 2026, buying an estimated $53.1K and bringing the position to 3,046 shares worth $3.65M. The position accounts for 0.71% of the portfolio, ranked #30.

Fortitude Family Office first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. 1,749 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Fortitude Family Office held 3,046 shares of Eli Lilly worth $3.65M as of Q2 2026.
  • Fortitude Family Office bought 52 Eli Lilly shares in Q2 2026, an estimated $53.1K.
  • Eli Lilly made up 0.71% of Fortitude Family Office's portfolio in Q2 2026, its #30 holding.
  • Fortitude Family Office first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
  • 1,749 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Fortitude Family Office's 13F filing for Q2 2026, filed 20 Jul 2026.